 Reema Wahdan-Alaswad
Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Hormones | 2 | 2023 | 67 | 1.420 |
Why?
| | Metformin | 5 | 2017 | 318 | 1.160 |
Why?
| | Breast Neoplasms | 6 | 2023 | 2452 | 0.970 |
Why?
| | Tamoxifen | 2 | 2023 | 217 | 0.800 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2016 | 215 | 0.730 |
Why?
| | Cell Cycle | 2 | 2023 | 596 | 0.720 |
Why?
| | Estrogen Receptor alpha | 1 | 2023 | 161 | 0.710 |
Why?
| | Estrogens | 1 | 2023 | 380 | 0.640 |
Why?
| | Up-Regulation | 3 | 2020 | 851 | 0.640 |
Why?
| | Hormone Replacement Therapy | 1 | 2020 | 106 | 0.610 |
Why?
| | TOR Serine-Threonine Kinases | 4 | 2013 | 449 | 0.570 |
Why?
| | Cell Proliferation | 7 | 2023 | 2496 | 0.550 |
Why?
| | Cell Line, Tumor | 11 | 2023 | 3540 | 0.540 |
Why?
| | MicroRNAs | 2 | 2014 | 701 | 0.520 |
Why?
| | Receptors, Estrogen | 1 | 2020 | 457 | 0.520 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2016 | 1455 | 0.480 |
Why?
| | Claudins | 1 | 2016 | 23 | 0.470 |
Why?
| | Smad5 Protein | 2 | 2012 | 7 | 0.460 |
Why?
| | Smad1 Protein | 2 | 2012 | 17 | 0.450 |
Why?
| | Fatty Acid Synthase, Type I | 1 | 2014 | 11 | 0.430 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2011 | 43 | 0.410 |
Why?
| | Transcriptome | 1 | 2020 | 1045 | 0.410 |
Why?
| | Carcinogenesis | 1 | 2016 | 229 | 0.410 |
Why?
| | Benzamides | 2 | 2017 | 224 | 0.400 |
Why?
| | Receptor, ErbB-3 | 1 | 2013 | 48 | 0.400 |
Why?
| | Prostatic Neoplasms | 4 | 2012 | 974 | 0.360 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2013 | 220 | 0.350 |
Why?
| | Signal Transduction | 7 | 2023 | 5226 | 0.340 |
Why?
| | Apoptosis | 4 | 2014 | 2430 | 0.330 |
Why?
| | Neoplastic Stem Cells | 1 | 2014 | 412 | 0.320 |
Why?
| | Sirolimus | 1 | 2012 | 281 | 0.320 |
Why?
| | Pyridines | 1 | 2013 | 605 | 0.290 |
Why?
| | Glucose | 1 | 2013 | 1047 | 0.270 |
Why?
| | Antineoplastic Agents | 3 | 2017 | 2194 | 0.250 |
Why?
| | Disease-Free Survival | 2 | 2020 | 769 | 0.240 |
Why?
| | Smad Proteins | 3 | 2016 | 43 | 0.220 |
Why?
| | Transforming Growth Factor beta | 3 | 2016 | 479 | 0.220 |
Why?
| | Hypoglycemic Agents | 2 | 2017 | 1387 | 0.220 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 928 | 0.200 |
Why?
| | Gene Expression Profiling | 3 | 2016 | 1782 | 0.190 |
Why?
| | Smad8 Protein | 2 | 2012 | 3 | 0.180 |
Why?
| | RNA Interference | 3 | 2013 | 476 | 0.170 |
Why?
| | Prostate | 2 | 2013 | 158 | 0.160 |
Why?
| | MCF-7 Cells | 1 | 2020 | 135 | 0.160 |
Why?
| | Mammary Neoplasms, Experimental | 2 | 2017 | 70 | 0.160 |
Why?
| | Cell Survival | 3 | 2012 | 1098 | 0.150 |
Why?
| | Mice, SCID | 1 | 2020 | 369 | 0.150 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2013 | 319 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 983 | 0.150 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2020 | 194 | 0.150 |
Why?
| | Blotting, Western | 2 | 2012 | 1187 | 0.140 |
Why?
| | Mice, Inbred NOD | 1 | 2020 | 610 | 0.140 |
Why?
| | Mice | 4 | 2023 | 18339 | 0.140 |
Why?
| | Animals | 9 | 2023 | 38058 | 0.140 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 965 | 0.140 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 881 | 0.130 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 25 | 0.130 |
Why?
| | Phosphorylation | 2 | 2012 | 1732 | 0.130 |
Why?
| | Receptors, Androgen | 1 | 2017 | 153 | 0.120 |
Why?
| | Gene Knock-In Techniques | 1 | 2016 | 61 | 0.120 |
Why?
| | Ovary | 1 | 2017 | 228 | 0.110 |
Why?
| | Epithelial Cells | 2 | 2013 | 1125 | 0.110 |
Why?
| | Humans | 13 | 2023 | 144759 | 0.110 |
Why?
| | Transcriptional Activation | 3 | 2013 | 383 | 0.110 |
Why?
| | Inhibitor of Differentiation Protein 1 | 2 | 2011 | 8 | 0.110 |
Why?
| | Mammary Glands, Human | 1 | 2014 | 67 | 0.100 |
Why?
| | Neoplasm Invasiveness | 1 | 2016 | 508 | 0.100 |
Why?
| | 3' Untranslated Regions | 1 | 2014 | 152 | 0.100 |
Why?
| | Oncogene Proteins | 1 | 2013 | 61 | 0.100 |
Why?
| | Mice, Knockout | 1 | 2020 | 3121 | 0.100 |
Why?
| | Mice, Nude | 2 | 2012 | 682 | 0.100 |
Why?
| | Cytostatic Agents | 1 | 2012 | 6 | 0.090 |
Why?
| | Female | 7 | 2023 | 78271 | 0.090 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1716 | 0.090 |
Why?
| | Neuroblastoma | 1 | 2013 | 174 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 2 | 2016 | 969 | 0.090 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 178 | 0.090 |
Why?
| | Microtubule-Associated Proteins | 1 | 2013 | 196 | 0.090 |
Why?
| | Receptors, Steroid | 1 | 2012 | 45 | 0.090 |
Why?
| | Muscle Proteins | 1 | 2013 | 244 | 0.090 |
Why?
| | LIM Domain Proteins | 1 | 2011 | 21 | 0.090 |
Why?
| | Biomarkers, Tumor | 2 | 2016 | 1313 | 0.090 |
Why?
| | Morpholines | 1 | 2012 | 128 | 0.090 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2012 | 105 | 0.090 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2012 | 142 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2016 | 2832 | 0.080 |
Why?
| | STAT3 Transcription Factor | 1 | 2012 | 207 | 0.080 |
Why?
| | Cohort Studies | 1 | 2020 | 5960 | 0.080 |
Why?
| | Prognosis | 2 | 2016 | 4282 | 0.080 |
Why?
| | Smad2 Protein | 1 | 2009 | 37 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 758 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2011 | 459 | 0.070 |
Why?
| | Nuclear Proteins | 1 | 2013 | 748 | 0.070 |
Why?
| | Rats | 5 | 2017 | 5597 | 0.070 |
Why?
| | Pyrimidines | 1 | 2012 | 532 | 0.070 |
Why?
| | Pyrazoles | 1 | 2012 | 509 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2027 | 0.060 |
Why?
| | Cell Line | 1 | 2010 | 2882 | 0.050 |
Why?
| | Obesity | 1 | 2017 | 3077 | 0.050 |
Why?
| | Rats, Wistar | 2 | 2017 | 451 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2013 | 744 | 0.040 |
Why?
| | RNA, Small Interfering | 2 | 2013 | 635 | 0.040 |
Why?
| | Male | 5 | 2013 | 72315 | 0.030 |
Why?
| | Phenylthiohydantoin | 1 | 2017 | 44 | 0.030 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 8 | 0.030 |
Why?
| | Ovariectomy | 1 | 2017 | 162 | 0.030 |
Why?
| | Steroids | 1 | 2017 | 160 | 0.030 |
Why?
| | Nitriles | 1 | 2017 | 205 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 454 | 0.030 |
Why?
| | Postmenopause | 1 | 2017 | 391 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 750 | 0.030 |
Why?
| | N-Myc Proto-Oncogene Protein | 1 | 2013 | 11 | 0.030 |
Why?
| | Testosterone | 1 | 2017 | 419 | 0.020 |
Why?
| | Autocrine Communication | 1 | 2013 | 38 | 0.020 |
Why?
| | Retinoblastoma Protein | 1 | 2013 | 61 | 0.020 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2013 | 57 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2017 | 780 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2017 | 652 | 0.020 |
Why?
| | Tretinoin | 1 | 2013 | 124 | 0.020 |
Why?
| | Sympathetic Nervous System | 1 | 2013 | 178 | 0.020 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2013 | 139 | 0.020 |
Why?
| | Aminosalicylic Acids | 1 | 2012 | 9 | 0.020 |
Why?
| | Benzenesulfonates | 1 | 2012 | 21 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 381 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2013 | 172 | 0.020 |
Why?
| | Down-Regulation | 1 | 2013 | 627 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 310 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2012 | 186 | 0.020 |
Why?
| | Drug Synergism | 1 | 2012 | 357 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 380 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 436 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2013 | 592 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2847 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2009 | 43 | 0.020 |
Why?
| | Lentivirus | 1 | 2009 | 60 | 0.020 |
Why?
| | Transduction, Genetic | 1 | 2009 | 133 | 0.020 |
Why?
| | Gene Silencing | 1 | 2009 | 205 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4557 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1496 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 4271 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2013 | 2050 | 0.010 |
Why?
|
|
Wahdan-Alaswad's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|